Citation 130868

HO,LK: DON,MJ: CHEN,HC: YEH,SF: CHEN,JM:. (1996). INHIBITION OF HEPATITIS B SURFACE ANTIGEN SECRETION ON HUMAN HEPATOMA CELLS. COMPONENTS FROM RUBIA CORDIFOLIA.. 59(3)

Citation Details

Title	INHIBITION OF HEPATITIS B SURFACE ANTIGEN SECRETION ON HUMAN HEPATOMA CELLS. COMPONENTS FROM RUBIA CORDIFOLIA.
Authors	HO,LK: DON,MJ: CHEN,HC: YEH,SF: CHEN,JM:
Year	1996
Volume	59
Issue	3

Summary

Year: 1996

Journal: Unknown

Organisms and Their Experiments (2)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	PMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FOR	FUROMOLLUGIN METHYL ETHER	None
2	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FOR	MOLLUGIN METHYL ETHER	None
3	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTED	MOLLUGIN,DIHYDRO:	None
4	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	MOLLUGIN,DIHYDRO:	ACTIVE
5	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MOLLUGIN,DIHYDRO:	WEAK ACTIVITY
6	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FOR	MOLLUGIN,ACETYL:	None
7	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	MOLLUGIN,ACETYL:	ACTIVE
8	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MOLLUGIN,ACETYL:	WEAK ACTIVITY
9	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FOR	RUBILACTONE METHYL ETHER	None
10	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RUBILACTONE METHYL ETHER	WEAK ACTIVITY

Rubia cordifolia (RUBIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OF	FUROMOLLUGIN	None
2	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	FUROMOLLUGIN	ACTIVE
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FUROMOLLUGIN	WEAK ACTIVITY
4	Not specified	ISOLATION AND IDENTIFICATION OF	MOLLUGIN	None
5	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	MOLLUGIN	ACTIVE
6	Not specified	ISOLATION AND IDENTIFICATION OF	RUBILACTONEANTHRAQUINONE,1-3-6-TRIHYDROXY-2-METHYL:ANTHRAQUINONE,1-3-6-TRIHYDROXY-2-METHYL: 3-O-(3'-O-ACETYL)-ALPHA-RHAMNOSYL(1-2)-GLUCOSIDEANTHRAQUINONE,1-3-6-TRIHYDROXY-2-METHYL: 3-O-ALPHA-RHAMNOSYL(1-2)-GLUCOSIDE	None
7	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RUBILACTONEANTHRAQUINONE,1-3-6-TRIHYDROXY-2-METHYL:ANTHRAQUINONE,1-3-6-TRIHYDROXY-2-METHYL: 3-O-(3'-O-ACETYL)-ALPHA-RHAMNOSYL(1-2)-GLUCOSIDEANTHRAQUINONE,1-3-6-TRIHYDROXY-2-METHYL: 3-O-ALPHA-RHAMNOSYL(1-2)-GLUCOSIDE	WEAK ACTIVITY
8	Not specified	ISOLATION AND IDENTIFICATION OF	ANTHRAQUINONE,1-HYDROXY-2-METHYL:	None

Show SPARQL Queries (1)